Oramed Pharmaceuticals authorizes share buyback program

Oramed Pharmaceuticals ( NASDAQ: ORMP ) said its board has authorized a common stock repurchase plan for the buy-back of up to $20M in maximum value of its common stock. Press Release More on Oramed Pharmaceuticals Seeking Alpha’s Quant Rating on Oramed Pharmaceuticals Historical earnings data for Oramed Pharmaceuticals Financial information for Oramed Pharmaceuticals.